Arima Genomics is a pioneering company in the field of 3D genomics, providing advanced solutions that drive discovery and innovation in life sciences. The company serves a diverse range of clients, including translational and clinical researchers, by offering cutting-edge tools and technologies that enable a deeper understanding of gene regulation and disease mechanisms. Operating in the genomics market, Arima Genomics focuses on the development and commercialization of products like the Arima HiC Kit, which allows for reproducible 3D genome conformation analysis. The business model revolves around selling these high-quality kits and related services, generating revenue through direct sales to research institutions and pharmaceutical companies. By leveraging the power of 3D genomic information, Arima Genomics helps uncover novel biomarkers and therapeutic targets, particularly in cancer research. The company is grounded in science, driven by innovation, and focused on improving human health through its state-of-the-art genomic solutions.

Keywords: 3D genomics, gene regulation, cancer research, biomarkers, therapeutic targets, HiC Kit, chromatin structure, life sciences, translational research, clinical research.